- In late August 2026, Veeva Systems reported second‑quarter results showing revenue of US$927.96 million and net income of US$273.43 million, alongside higher full‑year guidance and new global Vault CRM commitments from Biogen and Regeneron.
- Together with an executive leadership change, these earnings and AI‑driven CRM wins highlight how Veeva is tying life sciences customer growth to its emerging agentic and data‑rich platform capabilities.
- Next, we’ll examine how Veeva’s stronger guidance and AI‑enabled Vault CRM wins shape the existing investment narrative for the company.
Uncover the next big thing with 22 elite penny stocks that balance risk and reward.
Veeva Systems Investment Narrative Recap
To own Veeva Systems, you have to believe life sciences customers will keep deepening their use of Veeva’s cloud and AI agents across critical workflows, not just CRM. The latest quarter’s higher guidance and large Vault CRM wins appear to reinforce AI as the key near term catalyst, while also heightening the importance of maintaining differentiation against larger platform competitors, which remains one of the biggest risks to the story today.
Among the recent announcements, Biogen and Regeneron’s global commitments to Vault CRM stand out as most relevant to this earnings beat. These deals support the idea that Veeva’s AI infused CRM and Commercial Evidence tools are gaining traction with top tier customers, which ties directly into the catalyst around expanding multi product suites and embedding agentic capabilities more deeply across commercial workflows.
Yet, even with these AI wins, investors should be aware of how customer concentration and competitive pressure could still…
Read the full narrative on Veeva Systems (it’s free!)
Veeva Systems’ narrative projects $4.7 billion revenue and $1.4 billion earnings by 2029.
Uncover how Veeva Systems’ forecasts yield a $251.43 fair value, a 9% downside to its current price.
Exploring Other Perspectives
Some of the lowest tier analysts were assuming around US$4.5 billion of revenue and US$1.3 billion of earnings by 2029, which paints a more cautious picture than the upbeat AI driven catalyst narrative, and highlights how your view on whether AI agents truly embed Veeva more deeply into customer workflows can lead to very different conclusions that may need updating after this latest report.
Explore 12 other fair value estimates on Veeva Systems – why the stock might be worth as much as 38% more than the current price!
Decide For Yourself
Don’t just follow the ticker – dig into the data and build a conviction that’s truly your own.
- A great starting point for your Veeva Systems research is our analysis highlighting 3 key rewards that could impact your investment decision.
- Our free Veeva Systems research report provides a comprehensive fundamental analysis summarized in a single visual – the Snowflake – making it easy to evaluate Veeva Systems’ overall financial health at a glance.
Contemplating Other Strategies?
Our top stock finds are flying under the radar-for now. Get in early:
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 18 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
- Find 45 companies with promising cash flow potential yet trading below their fair value.
- The future of work is here. Discover the 38 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
New:Manage All Your Stock Portfolios in One Place
We’ve created the ultimate portfolio companion for stock investors, and it’s free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks
Have feedback on this article? Concerned about the content? Get in touch with us directly.Alternatively, email editorial-team@simplywallst.com
MI
mitchell_lawler
The Foxhole
A landmark settlement is meant to punish Meta (META). If the 1998 tobacco deal is any guide, it might protect it.
Any moat with an opt-out clause for your competitors is just a fence around your own garden.
Worth looking at what previous legal action actually did to Meta rather than reaching for tobacco. The FTC’s record five billion dollar privacy fine in 2019 was met with the stock rising, because it came in below fears and removed an open question. GDPR was designed to constrain large platforms and increased their share of the European ad market, because compliance cost fell hardest on small intermediaries. The FTC’s antitrust case, the one that could genuinely have broken the company up, was decided in Meta’s favour last November. The only thing that ever meaningfully hurt the business was Apple changing a tracking default, and Meta out-spent that too, while the ad-tech firms that could not afford to rebuild disappeared. The pattern is not that Meta survives regulation. It is that regulation keeps costing its smaller competitors more.
Great earnings season, but are the earnings real?
At first glance, this was the strongest earnings season in years. But when you look at where the growth actually came from, the story splits into two very different pictures.
10
Aug 28, 2026
About NYSE:VEEV
Veeva Systems
Provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.
Flawless balance sheet with solid track record.
Similar Companies
Market Insights
Great earnings season, but are the earnings real?AN
Andrew Legget
Which payment stocks actually get paid?MI
Mitchell Lawler
Picking portfolio winners takes more than hot airAN
Andrew Legget
Advertisement
Weekly Picks
Lou_Baseneseon Oncolytics Biotech·12 days ago
The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech
Fair Value:US$3.575.5% undervalued
31followersusers have followed this narrative
·0commentsusers have commented on this narrative
·7likesusers have liked this narrative
TR
tripledubon Meta Platforms·26 days ago
The $135 Billion Bet That Should Make Every Shareholder Nervous
Taloson Voyager Technologies·21 days ago
The “Landlord of Orbit” – A Deep Value Play Ahead of the Starlab Era
Ivoedon Uber Technologies·15 days ago
Uber’s Valuation Depends On Who Captures The Economics Of Driverless Rides
RecentlyUpdated Narratives
RockeTelleron Kuya Silver·about 4 hours ago
Kuya Silver, The High-Octane Rocket With 15,372 g/t Silver + $12 AISC
Fair Value:CA$10.8493.3% undervalued
10followersusers have followed this narrative
·1commentusers have commented on this narrative
·1likeusers have liked this narrative
RO
Robboon Unilever·about 5 hours ago
Unilever (LSE:ULVR), changes in the wind.
tripledubon Dusk Group·about 7 hours ago
Buying a Dollar for Fifty Cents: The Case for Dusk Group
Popular Narratives
oscargarciaon NVIDIA·3 months ago
The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.
CubanEroson Microsoft·about 2 months ago
A wonderful business at reasonable price.
Fair Value:US$419.9122.3% overvalued
212followersusers have followed this narrative
·0commentsusers have commented on this narrative
·9likesusers have liked this narrative
JO
John_Ericon MercadoLibre·24 days ago
